OBIO
Orchestra BioMed Holdings Inc

524
Mkt Cap
$271.54M
Volume
474,947.00
52W High
$5.42
52W Low
$2.20
PE Ratio
-3.60
OBIO Fundamentals
Price
$4.64
Prev Close
$4.64
Open
$4.58
50D MA
$4.22
Beta
1.72
Avg. Volume
196,788.81
EPS (Annual)
-$1.11
P/B
4.94
Rev/Employee
$389,325.58
$133.88
Loading...
Loading...
News
all
press releases
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven research firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold reco...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
HC Wainwright Has Optimistic Outlook of OBIO Q1 Earnings
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Free Report) - HC Wainwright boosted their Q1 2026 earnings per share estimates for Orchestra BioMed in a report released on Monday, March 16th. HC...
MarketBeat·4d ago
News Placeholder
Orchestra BioMed (NASDAQ:OBIO) Insider Purchases 10,000 Shares
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) insider David Hochman acquired 10,000 shares of Orchestra BioMed stock in a transaction that occurred on Friday, March 13th. The stock...
MarketBeat·5d ago
News Placeholder
Orchestra BioMed (NASDAQ:OBIO) Raised to Hold at Wall Street Zen
Wall Street Zen raised shares of Orchestra BioMed from a "strong sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·8d ago
News Placeholder
Orchestra BioMed (NASDAQ:OBIO) Receives "Buy" Rating from Chardan Capital
Chardan Capital reiterated a "buy" rating and set a $20.00 target price on shares of Orchestra BioMed in a research report on Thursday...
MarketBeat·9d ago
News Placeholder
Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates
Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of +168.87% and +3,813.54%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of +2,100.00% and +1.61%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the seven research firms that are covering the company...
MarketBeat·28d ago
News Placeholder
Orchestra BioMed (NASDAQ:OBIO) Trading 4.2% Higher - Here's What Happened
Orchestra BioMed (NASDAQ:OBIO) Shares Up 4.2% - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are presently covering the firm, MarketBeat...
MarketBeat·3mo ago
<
1
2
...
>

Latest OBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.